Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Horikoshi

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Gan No Rinsho. Japan Journal of Cancer Clinics|April 1, 1989
[A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy]K Shinagawa, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1987
[Phase II study of chlorambucil in patients with hematological malignancies]K Inoue, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1992
[Phase I and pharmacokinetic study of SM-5887 by 5-day schedule]K Inoue, A Matsumura, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1982
[Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver]H Miyamoto, M Ogawa, J Inagaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancerK Inoue, M Ogawa, J Inagaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1986
[Phase II study of medroxyprogesterone acetate in advanced breast cancer]K Ueno, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1982
[A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma]M Domyo, M Ogawa, J Inagaki, et al.
Nuclear Medicine Communications|September 1, 1994
Reliability of data obtained by radionuclide angiocardiography in follow-up studies with special reference to intra- and interobserver variationsH Oyamada, Y Yamada, E Nomura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer]H Ozeki, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1983
[Co-administration of adriamycin and 5-fluorouracil for the treatment of advanced stomach cancer]K Inoue, M Ogawa, J Inagaki, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Gan No Rinsho. Japan Journal of Cancer Clinics|April 1, 1989
[A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy]K Shinagawa, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1987
[Phase II study of chlorambucil in patients with hematological malignancies]K Inoue, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1992
[Phase I and pharmacokinetic study of SM-5887 by 5-day schedule]K Inoue, A Matsumura, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1982
[Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver]H Miyamoto, M Ogawa, J Inagaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancerK Inoue, M Ogawa, J Inagaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1986
[Phase II study of medroxyprogesterone acetate in advanced breast cancer]K Ueno, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1982
[A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma]M Domyo, M Ogawa, J Inagaki, et al.
Nuclear Medicine Communications|September 1, 1994
Reliability of data obtained by radionuclide angiocardiography in follow-up studies with special reference to intra- and interobserver variationsH Oyamada, Y Yamada, E Nomura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1988
[Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer]H Ozeki, M Ogawa, N Horikoshi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1983
[Co-administration of adriamycin and 5-fluorouracil for the treatment of advanced stomach cancer]K Inoue, M Ogawa, J Inagaki, et al.
Pageof 14